Media Summary: What should a company do when they receive a warning letter from the On September 9, 2022, the U.S. Food and Drug Administration ( I'll be talking to you today about some best practices for navigating the presubmission

Webinar How To Handle Fda - Detailed Analysis & Overview

What should a company do when they receive a warning letter from the On September 9, 2022, the U.S. Food and Drug Administration ( I'll be talking to you today about some best practices for navigating the presubmission Doug Marshall, Ph.D., Chief Scientific Officer, reviews recent

Photo Gallery

Webinar: How To Handle FDA Warning Letters
Webinar: Meeting FDA Requirements for BLE Mobile Medical Apps | Orthogonal
QMSR Final Rule: Meeting FDA’s New Requirements
Public Webinar: Patient-Focused Drug Development Draft Guidance 3
FDA Webinar on the Food Traceability Final Rule
NIH-FDA Webinar – Best Practices for Navigating the IDE Pre-submission process with FDA
What you Need to Know  FDA, FSMA & USDA Updates Webinar
Always Inspection-Ready: Mastering FDA Inspection Preparation and Response
CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products
Webinar: Modern Process Validation
FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)
FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment
View Detailed Profile
Webinar: How To Handle FDA Warning Letters

Webinar: How To Handle FDA Warning Letters

What should a company do when they receive a warning letter from the

Webinar: Meeting FDA Requirements for BLE Mobile Medical Apps | Orthogonal

Webinar: Meeting FDA Requirements for BLE Mobile Medical Apps | Orthogonal

This video is a recording of a live

QMSR Final Rule: Meeting FDA’s New Requirements

QMSR Final Rule: Meeting FDA’s New Requirements

On 2 February 2024,

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

Public Webinar: Patient-Focused Drug Development Draft Guidance 3

On September 9, 2022, the U.S. Food and Drug Administration (

FDA Webinar on the Food Traceability Final Rule

FDA Webinar on the Food Traceability Final Rule

The U.S. Food & Drug Administration (

NIH-FDA Webinar – Best Practices for Navigating the IDE Pre-submission process with FDA

NIH-FDA Webinar – Best Practices for Navigating the IDE Pre-submission process with FDA

I'll be talking to you today about some best practices for navigating the presubmission

What you Need to Know  FDA, FSMA & USDA Updates Webinar

What you Need to Know FDA, FSMA & USDA Updates Webinar

Doug Marshall, Ph.D., Chief Scientific Officer, reviews recent

Always Inspection-Ready: Mastering FDA Inspection Preparation and Response

Always Inspection-Ready: Mastering FDA Inspection Preparation and Response

With the

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

CDRH - REdI Annual Conference 2026: Innovative Regulatory Strategies to Advance Medical Products

Learn directly from the

Webinar: Modern Process Validation

Webinar: Modern Process Validation

The objective of the

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

FDA Webinar on the Infant Formula Transition Plan for Exercise of Enforcement Discretion (Part 1)

The U.S. Food & Drug Administration (

FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment

FDA | NIH: Regulatory Do’s and Don'ts: Tips from FDA – CDER Segment

This inaugural

FDA Best Audit Practices - Do's and Don'ts

FDA Best Audit Practices - Do's and Don'ts

Register @OnlineAudioWebinar for the full video, ...